Lucid Diagnostics Inc. - stock earnings
LUCD Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -14.2 million USD | 783000 USD |
2023Q2 | -11.4 million USD | 159000 USD |
2023Q1 | -2.0 billion USD | 446000 USD |
2022Q4 | -14.8 million USD | 112000 USD |
2022Q3 | -14.3 million USD | 76000 USD |
2022Q2 | -14.6 million USD | ? USD |
2022Q1 | -11.3 million USD | 300000 USD |
2021Q4 | -11.3 million USD | 300000 USD |
2021Q3 | -7.0 million USD | 200000 USD |
2021Q2 | -6.2 million USD | ? USD |
2021Q1 | -3.7 million USD | ? USD |
2020Q4 | -2.7 million USD | ? USD |
2020Q3 | -2.0 million USD | ? USD |
LUCD Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -56.8 million USD | 1.5 million USD |
2022 | -56.2 million USD | 377000 USD |
2021 | -28.7 million USD | 500000 USD |
2020 | -8.3 million USD | ? USD |
2019 | -4.4 million USD | ? USD |
2018 | -1.7 million USD | ? USD |
LUCD
Price: $0.69
52 week price:
Earnings Per Share: -1.26 USD
P/E Ratio: -0.89
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Volume: 72027
Market Capitalization: 44.2 million